Literature DB >> 520401

Bioavailability and pharmacokinetics of cimetidine.

A Grahnén, C von Bahr, B Lindström, A Rosén.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 520401     DOI： 10.1007/BF00605632

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  17 in total

1.  Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in man.

Authors:  K C Kwan; G O Breault; E R Umbenhauer; F G McMahon; D E Duggan
Journal:  J Pharmacokinet Biopharm       Date:  1976-06

2.  Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.

Authors:  W L Burland; W A Duncan; T Hesselbo; J G Mills; P C Sharpe; S J Haggie; J H Wyllie
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

3.  Cimetidine in the treatment of duodenal ulcer: a multicenter double blind study.

Authors:  H J Binder; A Cocco; R J Crossley; W Finkelstein; R Font; G Friedman; J Groarke; W Hughes; A F Johnson; J E McGuigan; R Summers; R Vlahcevic; E C Wilson; D H Winship
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

Review 4.  Individual differences in the disposition of drugs metabolised in the body.

Authors:  G Alvan
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

5.  Clearance concepts in pharmacokinetics.

Authors:  M Rowland; L Z Benet; G G Graham
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

6.  Bioavailability of cimetidine in man.

Authors:  S S Walkenstein; J W Dubb; W C Randolph; W J Westlake; R M Stote; A P Intoccia
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

7.  Cimetidine for ever (and ever and ever...)?

Authors: 
Journal:  Br Med J       Date:  1978-06-03

8.  High-pressure liquid chromatographic determination of cimetidine sulphoxide in human blood and urine.

Authors:  R M Lee; P M Osborne
Journal:  J Chromatogr       Date:  1978-09-01

9.  Fluoride bioavailability after intravenous and oral administration: importance of renal clearance and urine flow.

Authors:  J Ekstrand; M Ehrnebo; L O Boréus
Journal:  Clin Pharmacol Ther       Date:  1978-03       Impact factor: 6.875

10.  Cimetidine in patients with gastric ulcer: a multicentre controlled trial.

Authors:  F Frost; I Rahbek; S J Rune; K B Jensen; E Gudmand-Hoyer; E Krag; J Rask-Madsen; H R Wulff; J Garbol; K G Jensen; M Hojlund; V R Nissen
Journal:  Br Med J       Date:  1977-09-24
View more
  40 in total

1.  Elucidating the role of dose in the biopharmaceutics classification of drugs: the concepts of critical dose, effective in vivo solubility, and dose-dependent BCS.

Authors:  Georgia Charkoftaki; Aristides Dokoumetzidis; Georgia Valsami; Panos Macheras
Journal:  Pharm Res       Date:  2012-07-04       Impact factor: 4.200

Review 2.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

Review 3.  Multiple peaking phenomena in pharmacokinetic disposition.

Authors:  Neal M Davies; Jody K Takemoto; Dion R Brocks; Jaime A Yáñez
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

Review 4.  Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.

Authors:  J H Lin
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

5.  Gastric pH influences the appearance of double peaks in the plasma concentration-time profiles of cimetidine after oral administration in dogs.

Authors:  V Mummaneni; G L Amidon; J B Dressman
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

Review 6.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

7.  Cimetidine-a clinical and pharmacokinetic study.

Authors:  J Webster; H E Barber; G M Hawksworth; T A Jeffers; J Petersen; J C Petrie; P W Brunt; N A Mowat; R Griffiths
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

Review 8.  Sex-related differences in drug disposition in man.

Authors:  K Wilson
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

9.  Effect of pancreatico-biliary secretions and GI transit time on the absorption and pharmacokinetic profile of ranitidine in humans.

Authors:  K S Reynolds; M H Song; W D Heizer; C B Burns; D A Sica; K L Brouwer
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

10.  The role of ranitidine infusion on glucose, insulin and C-peptide serum levels induced by oral glucose tolerance test in healthy subjects.

Authors:  S Gentile; R Marmo; A Costume; C Orlando; R D'Alessandro; G De Bellis; M Porcellini; M Coltorti
Journal:  Acta Diabetol Lat       Date:  1986 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.